Patent · US Active

Antibody capable of blocking CD47-SIRPa interaction and application thereof

US11820820B2 · kind B2 · utility

0Cited by
3References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 10, 2019
Grant dateNov 21, 2023
Priority date—
Expiry dateJun 10, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An antibody capable of blocking CD47-SIRPa interaction and an application thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.